SAShynggys Adilgazyuly

Shynggys Adilgazyuly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shynggys Adilgazyuly has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Interpretable Machine Learning for Preliminary Lung Cancer Risk Assessment Based on Clinical Indicators and Lifestyle Factors

    by Indira Karymsakova, Dinara Kozhakhmetova, Dinara Shyrynkhanova, Dariga Bekenova, Lazzat Kydyralina, Alina Bugubayeva, Shynggys Adilgazyuly

    Background/Objective: Lung cancer remains a leading cause of cancer-related mortality, and access to low-dose CT screening is limited in resource-constrained settings. This study aimed to develop and evaluate an interpretable machine learning model for preliminary, symptom-based lung cancer risk discrimination using clinical indicators and lifestyle factors, without requiring imaging. Methods: A cross-sectional dataset of 561 participants (38 with a prior lung cancer diagnosis), following exclusion of a minors-eligible age bracket for which independent age verification was not possible, was analyzed. Five machine learning algorithms (Logistic Regression, Random Forest, XGBoost, LightGBM, CatBoost) were compared using a leakage-free pipeline, with ADASYN class balancing and hyperparameter tuning performed exclusively within cross-validation folds; feature selection was verified to be stable across folds (98% average overlap with the final feature set). The final model was selected solely on the basis of repeated cross-validated performance, without reference to the test set. Model interpretability was assessed using LIME, and a four-tier risk stratification system was developed and calibrated. Results: Random Forest achieved the best cross-validated F1-score (0.850 ± 0.092) among the five candidates and, given a clinically motivated preference for higher sensitivity at comparable F1, was selected as the final model. On the independent test set (n = 113), it achieved Accuracy = 0.956, Recall = 0.875, F1-score = 0.737, and AUC-ROC = 0.912. Sensitivity analysis indicated moderate reliance on a potential diagnostic proxy feature, and balancing-method comparisons (ADASYN, random oversampling, class weighting) confirmed that conclusions were not contingent on the specific resampling technique. Conclusions: The proposed model demonstrates solid discriminative performance and interpretability; however, given the cross-sectional design and limited number of positive cases, results should be interpreted as preliminary risk discrimination rather than validated early-detection prediction, warranting further prospective validation.